Announcements and Notices - [Discloseable Transaction] DISCLOSEABLE TRANSACTION IN RELATION TO CONSTRUCTION AGREEMENT FOR THE GLOBAL RESEARCH AND DEVELOPMENT CENTRE
Announcements and Notices - [Issue of Shares under a General Mandate / Other - Miscellaneous] (1) GRANT OF AWARD SHARES UNDER RESTRICTED SHARE AWARD SCHEME (2) ISSUE OF NEW SHARES UNDER GENERAL MANDATE (3) AMENDMENT TO SCHEME RULES
Announcements and Notices - [Terms of Reference of Other Board Committees] Terms of Reference for the Strategy and ESG Committee
Announcements and Notices - [Continuing Connected Transaction] CONTINUING CONNECTED TRANSACTIONS IN RELATION TO TECHNICAL SERVICE AGREEMENT AND BUSINESS DEVELOPMENT SERVICE AGREEMENT
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - ENTERING INTO OF AN EXCLUSIVE PROMOTION SERVICE AGREEMENT WITH A WHOLLY-OWNED SUBSIDIARY OF JIMIN KEXIN PHARMACEUTICAL IN RESPECT OF PUSINTIN (BEVACIZUMAB INJECTION, PUSINTIN) FOR THE MAINLAND CHINA MARKET
Announcements and Notices - [Connected Transaction] CONNECTED TRANSACTION IN RELATION TO DISPOSAL OF LISTED SECURITIES
Announcements and Notices - [Inside Information / Other - Business Update] INSIDE INFORMATION ANNOUNCEMENT - MARKETING APPROVAL FOR PUSINTIN (TAB008, BEVACIZUMAB INJECTION, PUSINTIN) OBTAINED FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Announcements and Notices - [Discloseable Transaction] DISCLOSEABLE TRANSACTION IN RELATION TO FORMATION OF JOINT VENTURE
Announcements and Notices - [Inside Information / Other - Trading Update] CERTAIN UNAUDITED FINANCIAL INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2021
Announcements and Notices - [Interim Results] INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2021
Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING
Announcements and Notices - [Results of AGM] POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 25 JUNE 2021
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL FOR TEMOZOLOMIDE CAPSULE (TOZ309) OBTAINED FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Announcements and Notices - [Notice of AGM] NOTICE OF ANNUAL GENERAL MEETING
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - MARKETING APPROVAL FOR MEGESTROL ACETATE ORAL SUSPENSION (TOM218) OBTAINED FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Announcements and Notices - [Inside Information / Other - Trading Update] CERTAIN UNAUDITED FINANCIAL INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2021
Announcements and Notices - [Final Results] ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2020
Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL APPLICATION OF TAB014 AUTHORIZED BY FDA